11/07/2024 | Press release | Distributed by Public on 11/07/2024 06:06
Current Guidance | |
Total Revenue | Flat |
Adjusted EBITDA 1,2
|
$435M - $450M |
Free Cash Flow Conversion | +25% |
Three months ended | ||||||||||
September 30, 2024 | September 30, 2023 | % Change | ||||||||
($ in millions, except per share data)
|
GAAP |
Non-GAAP1
|
Combined* Results |
Non-GAAP1 Adjusted* Results
|
GAAP to Combined Results | Non-GAAP | ||||
Total net sales | $ | 927.1 | $ | 927.1 | $ | 943.4 | $ | 943.3 | (1.7) | (1.7) |
Gross profit | $ | 236.6 | $ | 259.0 | $ | 239.9 | $ | 239.4 | (1.4) | 8.2 |
Gross margin | 25.5 | % | 27.9 | % | 25.4 | % | 25.4 | % | 10 bps | 250 bps |
Selling and administrative expense | $ | 164.6 | $ | 134.4 | $ | 155.0 | $ | 124.1 | 6.2 | 8.3 |
Research, development and engineering expense | $ | 23.4 | $ | 22.8 | $ | 22.5 | $ | 20.9 | 4.0 | 9.1 |
Operating profit (loss) | $ | 46.4 | $ | 101.8 | $ | 58.8 | $ | 95.0 | (21.1) | 7.2 |
Operating margin | 5.0 | % | 11.0 | % | 6.2 | % | 10.1 | % | (120) bps | 90 bps |
Net income (loss) | $ | (21.7) | $ | 20.5 | $ | 41.4 | $ | (85.2) | (152.4) | 124.1 |
Adjusted EBITDA | $ | 117.5 | $ | 109.1 | 7.7 |
Three months ended | |||||
Successor | Combined* | ||||
($ in millions) | September 30, 2024 | September 30, 2023 | % Change | ||
Net cash used by operating activities | $ | (15.5) | $ | (82.0) | 81.1 |
Excluding the impact of changes in cash of assets held for sale | - | 0.7 | (100.0) | ||
Capital expenditures | (3.8) | (7.4) | 48.6 | ||
Capitalized software development | (5.6) | (6.0) | 6.7 | ||
Free cash flow (use) (Non-GAAP measure) | $ | (24.9) | $ | (94.7) | 73.7 |
Nine months ended | |||||
Successor | Combined* | ||||
($ in millions) | September 30, 2024 | September 30, 2023 | % Change | ||
Net cash used by operating activities | $ | (47.0) | $ | (419.6) | 88.8 |
Excluding the impact of changes in cash of assets held for sale | - | 6.7 | (100.0) | ||
Capital expenditures | (12.2) | (18.6) | 34.4 | ||
Capitalized software development | (18.2) | (16.8) | (8.3) | ||
Free cash flow (use) (Non-GAAP measure) | $ | (77.4) | $ | (448.3) | 82.7 |
Revenue Summary by Reportable Segment & Business Line - Unaudited | ||||||||||
Three months ended September 30, | ||||||||||
2024 | 2023 |
2023 in CC3
|
||||||||
($ in millions) | Successor | Combined* | Combined* | % Change | % Change in CC | |||||
Banking | ||||||||||
Services | $ | 400.5 | $ | 401.4 | $ | 397.8 | (0.2) | % | 0.7 | % |
Products | 290.1 | 260.8 | 257.3 | 11.2 | % | 12.7 | % | |||
Total Banking Revenue | $ | 690.6 | $ | 662.2 | $ | 655.1 | 4.3 | % | 5.4 | % |
Retail | ||||||||||
Services | $ | 141.2 | $ | 144.7 | $ | 147.2 | (2.4) | % | (4.1) | % |
Products | 95.3 | 136.5 | 138.9 | (30.2) | % | (31.4) | % | |||
Total Retail Revenue | $ | 236.5 | $ | 281.2 | $ | 286.1 | (15.9) | % | (17.3) | % |
Total by Business Line | ||||||||||
Services | $ | 541.7 | $ | 546.1 | $ | 545.0 | (0.8) | % | (0.6) | % |
Products | 385.4 | 397.3 | 396.2 | (3.0) | % | (2.7) | % | |||
Total Revenue | $ | 927.1 | $ | 943.4 | $ | 941.2 | (1.7) | % | (1.5) | % |
3 - The company calculates constant currency (CC) by translating the prior-year period results at current year exchange rates.
|
Revenue Summary by Reportable Segment & Business Line - Unaudited | ||||||||||
Nine months ended September 30, | ||||||||||
2024 | 2023 |
2023 in CC3
|
||||||||
($ in millions) | Successor | Combined* | Combined* | % Change | % Change in CC | |||||
Banking | ||||||||||
Services | $ | 1,188.6 | $ | 1,182.7 | $ | 1,179.7 | 0.5 | % | 0.8 | % |
Products | 858.2 | 737.3 | 732.4 | 16.4 | % | 17.2 | % | |||
Total Banking Revenue | $ | 2,046.8 | $ | 1,920.0 | $ | 1,912.1 | 6.6 | % | 7.0 | % |
Retail | ||||||||||
Services | $ | 418.6 | $ | 417.8 | $ | 421.3 | 0.2 | % | (0.6) | % |
Products | 296.8 | 385.9 | 389.9 | (23.1) | % | (23.9) | % | |||
Total Retail Revenue | $ | 715.4 | $ | 803.7 | $ | 811.2 | (11.0) | % | (11.8) | % |
Total by Business Line | ||||||||||
Services | 1,607.2 | $ | 1,600.5 | $ | 1,601.0 | 0.4 | % | 0.4 | % | |
Products | 1,155.0 | 1,123.2 | 1,122.3 | 2.8 | % | 2.9 | % | |||
Total Revenue | $ | 2,762.2 | $ | 2,723.7 | $ | 2,723.3 | 1.4 | % | 1.4 | % |
3 - The company calculates constant currency (CC) by translating the prior-year period results at current year exchange rates.
|
Operating Profit Summary - Unaudited
|
||||||||||||||
Three months ended | ||||||||||||||
September 30, 2024 | September 30, 2023 | Change | ||||||||||||
($ in millions) | GAAP |
Non-GAAP4,5 Results
|
Combined* Results |
Non-GAAP4,5 Adjusted Combined* Results
|
Combined* vs GAAP Results | Non-GAAP Results | ||||||||
Services | $ | 541.7 | $ | 541.7 | $ | 546.1 | $ | 544.1 | $ | (4.4) | $ | (2.4) | ||
Products | 385.4 | 385.4 | 397.3 | 399.2 | (11.9) | (13.8) | ||||||||
Total net sales | $ | 927.1 | $ | 927.1 | $ | 943.4 | $ | 943.3 | $ | (16.3) | $ | (16.2) | ||
Services | $ | 138.2 | $ | 153.4 | $ | 156.8 | $ | 155.5 | $ | (18.6) | $ | (2.1) | ||
Products | 98.4 | 105.6 | 83.1 | 83.9 | 15.3 | 21.7 | ||||||||
Total gross profit | $ | 236.6 | $ | 259.0 | $ | 239.9 | $ | 239.4 | $ | (3.3) | $ | 19.6 | ||
Services | 25.5 | % | 28.3 | % | 28.7 | % | 28.6 | % | (320) | bps | (30) | bps | ||
Products | 25.5 | % | 27.4 | % | 20.9 | % | 21.0 | % | 460 | bps | 640 | bps | ||
Total gross margin | 25.5 | % | 27.9 | % | 25.4 | % | 25.4 | % | 10 | bps | 250 | bps | ||
Selling and administrative expense | 164.6 | 134.4 | 155.0 | 124.1 | 9.6 | 10.3 | ||||||||
Research, development and engineering expense | 23.4 | 22.8 | 22.5 | 20.9 | 0.9 | 1.9 | ||||||||
Other operating expenses | 2.2 | - | 3.6 | (0.6) | (1.4) | 0.6 | ||||||||
Operating expenses | $ | 190.2 | $ | 157.2 | $ | 181.1 | $ | 144.4 | $ | 9.1 | $ | - | $ | 12.8 |
Operating profit | $ | 46.4 | $ | 101.8 | $ | 58.8 | $ | 95.0 | (12.4) | 6.8 | ||||
Operating margin | 5.0 | % | 11.0 | % | 6.2 | % | 10.1 | % | ||||||
Adjusted EBITDA | $ | 117.5 | $ | 109.1 | 8.4 | |||||||||
Adjusted EBITDA margin | 12.7 | % | 11.6 | % | ||||||||||
4 - See Note 1 below for GAAP to Non-GAAP adjustments to net sales, gross profit and operating expenses, which include selling and administrative expense, research, development and engineering expense, gain/loss on sales of assets, net, and impairment of assets.
|
||||||||||||||
5- Refer to Note 1 below for further information regarding adjustments for Non-GAAP which excludes the results of the non-core business that was sold in September 2023.
|
Nine months ended | ||||||||||||
September 30, 2024 | September 30, 2023 | Change | ||||||||||
($ in millions) | GAAP |
Non-GAAP 4,5 Results
|
Combined* Results |
Non-GAAP4,5 Adjusted Combined* Results
|
Combined* vs GAAP Results | Non-GAAP Results | ||||||
Services | $ | 1,607.2 | $ | 1,607.2 | $ | 1,600.5 | $ | 1,593.9 | $ | 6.7 | $ | 13.3 |
Products | 1,155.0 | 1,156.7 | 1,123.2 | 1,120.0 | 31.8 | 36.7 | ||||||
Total net sales | $ | 2,762.2 | $ | 2,763.9 | $ | 2,723.7 | $ | 2,713.9 | $ | 38.5 | $ | 50.0 |
Services | $ | 397.0 | $ | 456.0 | $ | 460.1 | $ | 463.9 | $ | (63.1) | $ | (7.9) |
Products | 291.4 | 309.6 | 214.3 | 212.8 | 77.1 | 96.8 | ||||||
Total gross profit | $ | 688.4 | $ | 765.6 | $ | 674.4 | $ | 676.7 | $ | 14.0 | $ | 88.9 |
Services | 24.7 | % | 28.4 | % | 28.7 | % | 29.1 | % | (400) | bps | (70) | bps |
Products | 25.2 | % | 26.8 | % | 19.1 | % | 19.0 | % | 610 | bps | 780 | bps |
Total gross margin | 24.9 | % | 27.7 | % | 24.8 | % | 24.9 | % | 10 | bps | 280 | bps |
Selling and administrative expense | 478.4 | 405.4 | 539.8 | 395.3 | (61.4) | 10.1 | ||||||
Research, development and engineering expense | 69.7 | 66.4 | 74.3 | 66.6 | (4.6) | (0.2) | ||||||
Other operating expenses | (0.6) | (0.1) | 7.5 | (0.1) | (8.1) | - | ||||||
Operating expenses | $ | 547.5 | $ | 471.7 | $ | 621.6 | $ | 461.8 | $ | (74.1) | $ | 9.9 |
Operating profit (loss) | $ | 140.9 | $ | 293.9 | $ | 52.8 | $ | 214.9 | $ | 88.1 | $ | 79.0 |
Operating margin | 5.1 | % | 10.6 | % | 1.9 | % | 7.9 | % | ||||
Adjusted EBITDA | $ | 339.7 | $ | 257.2 | $ | 82.5 | ||||||
Adjusted EBITDA margin | 12.3 | % | 9.5 | % | ||||||||
4 - See Note 1 below for GAAP to Non-GAAP adjustments to net sales, gross profit and operating expenses, which include selling and administrative expense, research, development and engineering expense, gain/loss on sales of assets, net, and impairment of assets.
|
||||||||||||
5- Refer to Note 1 below for further information regarding adjustments for Non-GAAP which excludes the results of the non-core business that was sold in September 2023.
|
Gross Margin by Segment - Unaudited | ||||||||
Three months ended | ||||||||
September 30, 2024 | September 30, 2023 | |||||||
Non-GAAP Adjusted Combined* | ||||||||
($ in millions) | Banking |
Retail6
|
Banking |
Retail6
|
||||
Services | $ | 400.5 | $ | 141.2 | $ | 401.4 | $ | 142.7 |
Products | 290.1 | 95.3 | 263.6 | 135.6 | ||||
Total net sales | $ | 690.6 | $ | 236.5 | $ | 665.0 | $ | 278.3 |
Services | $ | 112.6 | $ | 40.9 | $ | 108.2 | $ | 47.3 |
Products | 85.7 | 19.8 | 56.2 | 27.7 | ||||
Total gross profit | $ | 198.3 | $ | 60.7 | $ | 164.4 | $ | 75.0 |
Services | 28.1 | % | 29.0 | % | 27.0 | % | 33.1 | % |
Products | 29.5 | % | 20.8 | % | 21.3 | % | 20.4 | % |
Total gross margin | 28.7 | % | 25.7 | % | 24.7 | % | 26.9 | % |
6 - Excludes the results of the non-core business that was sold during September 2023, and certain other non-recurring, non-operational charges detailed in the notes for Non-GAAP measures. Refer to Note 1 for further information.
|
Gross Margin by Segment - Unaudited | ||||||||
Nine months ended | ||||||||
September 30, 2024 | September 30, 2023 | |||||||
Non-GAAP Adjusted Combined* | ||||||||
($ in millions) | Banking |
Retail6
|
Banking |
Retail6
|
||||
Services | $ | 1,188.6 | $ | 418.6 | $ | 1,182.7 | $ | 411.2 |
Products | 858.2 | 296.8 | 740.1 | 379.9 | ||||
Total net sales | $ | 2,046.8 | $ | 715.4 | $ | 1,922.8 | $ | 791.1 |
Services | $ | 331.5 | $ | 124.6 | $ | 332.5 | $ | 131.4 |
Products | 245.1 | 64.4 | 137.4 | 75.4 | ||||
Total gross profit | $ | 576.6 | $ | 189.0 | $ | 469.9 | $ | 206.8 |
Services | 27.9 | % | 29.8 | % | 28.1 | % | 32.0 | % |
Products | 28.6 | % | 21.7 | % | 18.6 | % | 19.8 | % |
Total gross margin | 28.2 | % | 26.4 | % | 24.4 | % | 26.1 | % |
6 - Excludes the results of the non-core business that was sold during September 2023, and certain other non-recurring, non-operational charges detailed in the notes for Non-GAAP measures. Refer to Note 1 for further information.
|
Successor | ||||
9/30/2024 | 12/31/2023 | |||
ASSETS | ||||
Current assets | ||||
Cash, cash equivalents, and restricted cash | $ | 334.4 | $ | 592.3 |
Short-term investments | 11.3 | 13.4 | ||
Trade receivables, less allowances for doubtful accounts | 665.4 | 721.8 | ||
Inventories | 641.1 | 589.8 | ||
Other current assets | 246.5 | 236.6 | ||
Total current assets | 1,898.7 | 2,153.9 | ||
Securities and other investments | 6.7 | 6.5 | ||
Property, plant and equipment, net | 143.7 | 159.0 | ||
Deferred income taxes | 74.5 | 71.4 | ||
Goodwill | 619.6 | 612.3 | ||
Customer relationships, net | 522.7 | 543.0 | ||
Other intangible assets, net | 323.1 | 348.3 | ||
Other assets | 312.3 | 267.6 | ||
Total assets | $ | 3,901.3 | $ | 4,162.0 |
LIABILITIES AND EQUITY | ||||
Current liabilities | ||||
Notes payable | $ | 0.8 | $ | 0.3 |
Accounts payable | 479.0 | 529.0 | ||
Deferred revenue | 318.2 | 376.2 | ||
Other current liabilities | 513.7 | 515.5 | ||
Total current liabilities | 1,311.7 | 1,421.0 | ||
Long-term debt | 1,099.6 | 1,252.4 | ||
Other liabilities | 414.1 | 409.4 | ||
Total Diebold Nixdorf, Incorporated shareholders' equity | 1,066.2 | 1,063.8 | ||
Noncontrolling interests | 9.7 | 15.4 | ||
Total equity | 1,075.9 | 1,079.2 | ||
Total liabilities and equity | $ | 3,901.3 | $ | 4,162.0 |
Three months ended | ||||||||||
Successor | Successor | Predecessor | Q3 2023 | |||||||
September 30, 2024 | Period from 08/12/2023 through 09/30/2023 | Period from 07/01/2023 through 08/11/2023 | Adjustments | Combined* | ||||||
Net sales | ||||||||||
Services | $ | 541.7 | $ | 305.5 | $ | 240.6 | $ | - | $ | 546.1 |
Products | 385.4 | 286.3 | 111.0 | - | 397.3 | |||||
Total | 927.1 | 591.8 | 351.6 | - | 943.4 | |||||
Cost of sales | ||||||||||
Services | 403.5 | 226.1 | 171.3 | (8.1) | 389.3 | |||||
Products | 287.0 | 236.1 | 94.8 | (16.7) | 314.2 | |||||
Total | 690.5 | 462.2 | 266.1 | (24.8) | 703.5 | |||||
Gross profit | 236.6 | 129.6 | 85.5 | 24.8 | 239.9 | |||||
Gross margin | 25.5 | % | 21.9 | % | 24.3 | % | 25.4 | % | ||
Operating expenses | ||||||||||
Selling and administrative expense | 164.6 | 81.1 | 73.9 | 3.4 | 158.4 | |||||
Research, development and engineering expense | 23.4 | 12.0 | 10.5 | - | 22.5 | |||||
Loss (gain) on sale of assets, net | 0.6 | (1.5) | - | - | (1.5) | |||||
Impairment of assets | 1.6 | 1.1 | 0.6 | - | 1.7 | |||||
Total | 190.2 | 92.7 | 85.0 | 3.4 | 181.1 | |||||
Percent of net sales | 20.5 | % | 15.7 | % | 24.2 | % | 19.2 | % | ||
Operating profit (loss) | 46.4 | 36.9 | 0.5 | 21.4 | 58.8 | |||||
Operating margin | 5.0 | % | 6.2 | % | 0.1 | % | 6.2 | % | ||
Other income (expense) | ||||||||||
Interest income | 2.9 | 2.0 | 1.7 | - | 3.7 | |||||
Interest expense | (38.4) | (25.3) | (22.0) | 25.2 | (22.1) | |||||
Foreign exchange gain (loss), net | (2.9) | (27.3) | 7.9 | 4.7 | (14.7) | |||||
Reorganization items, net | - | (8.0) | 2,250.3 | (2,242.3) | - | |||||
Miscellaneous gain (loss), net | 1.7 | (0.8) | 6.2 | (3.4) | 2.0 | |||||
Total other income (expense) | (36.7) | (59.4) | 2,244.1 | (2,215.8) | (31.1) | |||||
Profit (loss) before taxes | 9.7 | (22.5) | 2,244.6 | (2,194.4) | 27.7 | |||||
Income tax expense (benefit) | 29.9 | (13.2) | 94.1 | (93.3) | (12.4) | |||||
Equity in earnings (loss) of unconsolidated subsidiaries, net | (1.5) | 1.1 | 0.2 | - | 1.3 | |||||
Net income (loss) | (21.7) | (8.2) | 2,150.7 | (2,101.1) | 41.4 | |||||
Net income (loss) attributable to noncontrolling interests | 0.7 | 0.7 | (0.2) | - | 0.5 | |||||
Net income (loss) attributable to Diebold Nixdorf, Incorporated | $ | (22.4) | $ | (8.9) | $ | 2,150.9 | $ | (2,101.1) | $ | 40.9 |
Basic weighted-average shares outstanding | 37.6 | 37.6 | 80.0 | |||||||
Diluted weighted-average shares outstanding | 37.6 | 37.6 | 81.4 | |||||||
Basic earnings (loss) per share | $ | (0.60) | $ | (0.24) | $ | 26.89 | ||||
Diluted earnings (loss) per share | $ | (0.60) | $ | (0.24) | $ | 26.42 |
Nine months ended | ||||||||||
Successor | Successor | Predecessor | Q3 YTD 2023 | |||||||
September 30, 2024 | Period from 08/12/2023 through 09/30/2023 | Period from 01/01/2023 through 08/11/2023 | Adjustments | Combined* | ||||||
Net sales | ||||||||||
Services | $ | 1,607.2 | $ | 305.5 | $ | 1,295.0 | $ | - | $ | 1,600.5 |
Products | 1,155.0 | 286.3 | 836.9 | - | 1,123.2 | |||||
Total | 2,762.2 | 591.8 | 2,131.9 | - | 2,723.7 | |||||
Cost of sales | ||||||||||
Services | 1,210.2 | 226.1 | 922.4 | (8.1) | 1,140.4 | |||||
Products | 863.6 | 236.1 | 689.5 | (16.7) | 908.9 | |||||
Total | 2,073.8 | 462.2 | 1,611.9 | (24.8) | 2,049.3 | |||||
Gross profit | 688.4 | 129.6 | 520.0 | 24.8 | 674.4 | |||||
Gross margin | 24.9 | % | 21.9 | % | 24.4 | % | 24.8 | % | ||
Operating expenses | ||||||||||
Selling and administrative expense | 478.4 | 81.1 | 458.7 | 3.4 | 543.2 | |||||
Research, development and engineering expense | 69.7 | 12.0 | 62.3 | - | 74.3 | |||||
Loss (gain) on sale of assets, net | (2.2) | (1.5) | 1.2 | - | (0.3) | |||||
Impairment of assets | 1.6 | 1.1 | 3.3 | - | 4.4 | |||||
Total | 547.5 | 92.7 | 525.5 | 3.4 | 621.6 | |||||
Percent of net sales | 19.8 | % | 15.7 | % | 24.6 | % | 22.8 | % | ||
Operating profit (loss) | 140.9 | 36.9 | (5.5) | 21.4 | 52.8 | |||||
Operating margin | 5.1 | % | 6.2 | % | (0.3) | % | 1.9 | % | ||
Other income (expense) | ||||||||||
Interest income | 10.1 | 2.0 | 6.7 | - | 8.7 | |||||
Interest expense | (120.6) | (25.3) | (173.6) | 25.2 | (173.7) | |||||
Foreign exchange gain (loss), net | 5.1 | (27.3) | (1.2) | 4.7 | (23.8) | |||||
Reorganization items, net | - | (8.0) | 1,614.1 | (1,606.1) | - | |||||
Miscellaneous gain (loss), net | 5.3 | (0.8) | 12.3 | (3.4) | 8.1 | |||||
Total other income (expense) | (100.1) | (59.4) | 1,458.3 | (1,579.6) | (180.7) | |||||
Profit (loss) before taxes | 40.8 | (22.5) | 1,452.8 | (1,558.2) | (127.9) | |||||
Income tax expense (benefit) | 58.8 | (13.2) | 90.4 | (93.3) | (16.1) | |||||
Equity in earnings (loss) of unconsolidated subsidiaries, net | (2.9) | 1.1 | (0.5) | - | 0.6 | |||||
Net income (loss) | (20.9) | (8.2) | 1,361.9 | (1,464.9) | (111.2) | |||||
Net income (loss) attributable to noncontrolling interests | 1.2 | 0.7 | (0.8) | - | (0.1) | |||||
Net income (loss) attributable to Diebold Nixdorf, Incorporated | $ | (22.1) | $ | (8.9) | $ | 1,362.7 | $ | (1,464.9) | $ | (111.1) |
Basic weighted-average shares outstanding | 37.6 | 37.6 | 79.7 | |||||||
Diluted weighted-average shares outstanding | 37.6 | 37.6 | 81.4 | |||||||
Basic earnings (loss) per share | $ | (0.59) | $ | (0.24) | $ | 17.10 | ||||
Diluted earnings (loss) per share | $ | (0.59) | $ | (0.24) | $ | 16.74 |
Successor | Successor | Predecessor | ||||
Nine months ended | Period from | Period from | ||||
September 30, 2024 | 08/12/2023 through 09/30/2023 | 01/01/2023 through 08/11/2023 | ||||
Cash flow from operating activities | ||||||
Net income (loss) | $ | (20.9) | $ | (8.2) | $ | 1,361.9 |
Adjustments to reconcile net loss to cash flow used by operating activities: | ||||||
Depreciation and amortization | 25.8 | 7.3 | 35.5 | |||
Amortization of fair valued assets | 68.3 | 13.7 | 41.8 | |||
Amortization of deferred financing costs into interest expense | 1.3 | 0.9 | 21.8 | |||
Reorganization items (non-cash) | - | - | (1,747.6) | |||
Reorganization items (debt make whole premium) | - | - | 91.0 | |||
Share-based compensation | 7.4 | - | 5.1 | |||
Debt prepayment costs | 2.0 | - | - | |||
(Gain) loss on sale of assets, net | (1.8) | (1.5) | 1.2 | |||
Deferred income taxes | 2.0 | (50.3) | 79.8 | |||
Impairment of assets | 1.6 | 1.1 | 3.3 | |||
Other | (0.2) | - | - | |||
Changes in certain assets and liabilities: | ||||||
Trade receivables | 55.5 | (104.6) | 9.9 | |||
Inventories | (56.7) | 54.0 | (98.1) | |||
Accounts payable | (51.1) | 90.4 | (140.4) | |||
Income taxes | 7.0 | 27.7 | (26.0) | |||
Deferred revenue | (51.2) | (58.2) | (51.0) | |||
Certain other assets and liabilities | (36.0) | 23.1 | (3.2) | |||
Net cash used by operating activities | (47.0) | (4.6) | (415.0) | |||
Cash flow from investing activities | ||||||
Capital expenditures | (12.2) | (3.5) | (15.1) | |||
Capitalized software development | (18.2) | (3.7) | (13.1) | |||
Net short-term investment activity | 0.9 | (3.1) | 12.2 | |||
Proceeds from sale of assets | 1.3 | - | - | |||
Net cash used by investing activities | (28.2) | (10.3) | (16.0) | |||
Cash flow from financing activities | ||||||
Debt issuance costs | (4.6) | - | (5.1) | |||
Revolver, ABL, and FILO borrowings and repayments, net | 38.7 | - | (188.3) | |||
Repayment Exit facility | (200.0) | - | - | |||
Other debt borrowings | 0.6 | 4.9 | 1,254.4 | |||
Other debt repayments | (0.1) | (1.6) | (403.1) | |||
Debt prepayment costs | (2.0) | - | - | |||
Distributions to noncontrolling interest holders | (3.2) | |||||
Debt make whole premium | - | - | (91.0) | |||
Other | (3.9) | (0.5) | (3.4) | |||
Net cash (used), provided by financing activities | (174.5) | 2.8 | 563.5 | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (8.2) | (4.9) | 2.9 | |||
Change in cash, cash equivalents and restricted cash | (257.9) | (17.0) | 135.4 | |||
Add: Cash included in assets held for sale at beginning of period | - | 0.7 | 2.8 | |||
Less: Cash included in assets held for sale at end of period | - | - | 0.7 | |||
Cash, cash equivalents and restricted cash at the beginning of the period | 592.3 | 456.6 | 319.1 | |||
Cash, cash equivalents and restricted cash at the end of the period | $ | 334.4 | $ | 440.3 | $ | 456.6 |
Three months ended September 30, 2024 | ||||||||||||||||||||||||||
Successor | ||||||||||||||||||||||||||
Service Sales | Product Sales | Net Sales | COS - service | COS -product | COS | Gross Profit | % of Sales | SG&A | R&D | Other OPEX | OP | % of Sales | ||||||||||||||
GAAP | $ | 541.7 | $ | 385.4 | $ | 927.1 | $ | 403.5 | $ | 287.0 | $ | 690.5 | $ | 236.6 | 25.5 | % | $ | 164.6 | $ | 23.4 | $ | 2.2 | $ | 46.4 | 5.0 | % |
Restructuring and transition - personnel | - | - | - | (3.9) | (1.4) | (5.3) | 5.3 | (0.9) | (0.5) | - | 6.7 | |||||||||||||||
Transformation - other | - | - | - | 0.1 | - | 0.1 | (0.1) | (24.5) | - | (0.7) | 25.1 | |||||||||||||||
Financial restructuring costs | - | - | - | - | - | - | - | (2.1) | - | - | 2.1 | |||||||||||||||
Amortization of fair valued assets | - | - | - | (11.4) | (5.3) | (16.7) | 16.7 | (2.0) | (0.1) | - | 18.8 | |||||||||||||||
Legal deal matters | - | - | - | - | (0.5) | (0.5) | 0.5 | (0.7) | - | - | 1.2 | |||||||||||||||
Other | - | - | - | - | - | - | - | - | - | (1.5) | 1.5 | |||||||||||||||
Non-GAAP Adjusted results | $ | 541.7 | $ | 385.4 | $ | 927.1 | $ | 388.3 | $ | 279.8 | $ | 668.1 | $ | 259.0 | 27.9 | % | $ | 134.4 | $ | 22.8 | $ | - | $ | 101.8 | 11.0 | % |
Three months ended September 30, 2023 | ||||||||||||||||||||||||||
Combined* | ||||||||||||||||||||||||||
Service Sales | Product Sales | Net Sales | COS - service | COS -product | COS | Gross Profit | % of Sales | Selling, G&A | R, D & E | Other OPEX | OP | % of Sales | ||||||||||||||
Predecessor GAAP Results | $ | 240.6 | $ | 111.0 | $ | 351.6 | $ | 171.3 | $ | 94.8 | $ | 266.1 | $ | 85.5 | 24.3 | % | $ | 73.9 | $ | 10.5 | $ | 0.6 | 0.5 | 0.1 | % | |
Successor GAAP Results | 305.5 | 286.3 | 591.8 | 226.1 | 236.1 | 462.2 | 129.6 | 21.9 | % | 81.1 | 12.0 | (0.4) | 36.9 | 6.2 | % | |||||||||||
Impacts of Fresh Start Accounting | - | - | - | (8.1) | (16.7) | (24.8) | 24.8 | 3.4 | - | - | 21.4 | |||||||||||||||
Restructuring and transition - personnel | - | - | - | (1.8) | 1.8 | - | - | (7.4) | - | - | 7.4 | |||||||||||||||
Transformation - other | - | - | - | 3.2 | (0.2) | 3.0 | (3.0) | (5.5) | - | - | 2.5 | |||||||||||||||
Refinancing related costs | - | - | - | - | - | - | - | 0.2 | - | - | (0.2) | |||||||||||||||
Held for sale non-core business | (2.0) | (0.9) | (2.9) | (2.1) | (0.5) | (2.6) | (0.3) | (1.9) | (1.6) | 0.9 | 2.3 | |||||||||||||||
Amortization of fair valued assets | - | - | - | - | - | - | - | (18.0) | - | - | 18.0 | |||||||||||||||
Legal deal matters | - | 2.8 | 2.8 | - | - | - | 2.8 | (1.6) | - | - | 4.4 | |||||||||||||||
Crisis in Ukraine costs | - | - | - | - | - | (0.1) | - | - | 0.1 | |||||||||||||||||
Other impairment | - | - | - | - | - | - | - | - | - | (1.7) | 1.7 | |||||||||||||||
Non-GAAP Adjusted results | $ | 544.1 | $ | 399.2 | $ | 943.3 | $ | 388.6 | $ | 315.3 | $ | 703.9 | $ | 239.4 | 25.4 | % | $ | 124.1 | $ | 20.9 | $ | (0.6) | $ | 95.0 | 10.1 | % |
Three months ended | ||||||||||||
September 30, 2024 | September 30, 2023 | |||||||||||
Successor | Combined* | |||||||||||
Services | Products | Total | Services | Products | Total | |||||||
Predecessor Gross Profit | $ | - | $ | - | $ | - | $ | 69.3 | $ | 16.2 | $ | 85.5 |
Successor Gross Profit | 138.2 | 98.4 | 236.6 | 79.4 | 50.2 | 129.6 | ||||||
Impacts of Fresh Start Accounting | - | - | - | 8.1 | 16.7 | 24.8 | ||||||
Restructuring and transition - personnel | 3.9 | 1.4 | 5.3 | 1.8 | (1.8) | - | ||||||
Transformation - other | (0.1) | - | (0.1) | (3.2) | 0.2 | (3.0) | ||||||
Held for sale non-core business | - | - | - | 0.1 | (0.4) | (0.3) | ||||||
Amortization of fair valued assets | 11.4 | 5.3 | 16.7 | - | - | - | ||||||
Legal deal matters | - | 0.5 | 0.5 | - | 2.8 | 2.8 | ||||||
Non-GAAP Adjusted Gross Profit | $ | 153.4 | $ | 105.6 | $ | 259.0 | $ | 155.5 | $ | 83.9 | $ | 239.4 |
Nine months ended September 30, 2024 | ||||||||||||||||||||||||||
Successor | ||||||||||||||||||||||||||
Service Sales | Product Sales | Net Sales | COS - service | COS -product | COS | Gross Profit | % of Sales | SG&A | R&D | Other OPEX | OP | % of Sales | ||||||||||||||
GAAP | $ | 1,607.2 | $ | 1,155.0 | $ | 2,762.2 | $ | 1,210.2 | $ | 863.6 | $ | 2,073.8 | $ | 688.4 | 24.9 | % | $ | 478.4 | $ | 69.7 | $ | (0.6) | $ | 140.9 | 5.1 | % |
Restructuring and transition - personnel | - | - | - | (18.8) | (3.2) | (22.0) | 22.0 | (10.0) | (3.0) | - | 35.0 | |||||||||||||||
Transformation - other | - | - | - | (1.0) | - | (1.0) | 1.0 | (42.4) | - | (0.7) | 44.1 | |||||||||||||||
Financial restructuring costs | - | - | - | - | - | - | - | (14.1) | - | 0.1 | 14.0 | |||||||||||||||
Amortization of fair valued assets | - | - | - | (39.2) | (14.6) | (53.8) | 53.8 | (5.4) | (0.3) | - | 59.5 | |||||||||||||||
Divestitures and asset sales | - | - | - | - | - | - | - | - | - | 2.6 | (2.6) | |||||||||||||||
Legal deal matters | - | 1.7 | 1.7 | - | 0.2 | 0.2 | 1.5 | (1.1) | - | - | 2.6 | |||||||||||||||
Other | - | - | - | - | 1.1 | 1.1 | (1.1) | - | - | (1.5) | 0.4 | |||||||||||||||
Non-GAAP Adjusted results | $ | 1,607.2 | $ | 1,156.7 | $ | 2,763.9 | $ | 1,151.2 | $ | 847.1 | $ | 1,998.3 | $ | 765.6 | 27.7 | % | $ | 405.4 | $ | 66.4 | $ | (0.1) | $ | 293.9 | 10.6 | % |
Nine months ended September 30, 2023 | ||||||||||||||||||||||||||
Predecessor | ||||||||||||||||||||||||||
Service Sales | Product Sales | Net Sales | COS - service | COS -product | COS | Gross Profit | % of Sales | Selling, G&A | R, D & E | Other OPEX | OP | % of Sales | ||||||||||||||
Predecessor GAAP Results | $ | 1,295.0 | $ | 836.9 | $ | 2,131.9 | $ | 922.4 | $ | 689.5 | $ | 1,611.9 | $ | 520.0 | 24.4% | $ | 458.7 | $ | 62.3 | $ | 4.5 | $ | (5.5) | (0.3)% | ||
Successor GAAP Results | 305.5 | 286.3 | 591.8 | 226.1 | 236.1 | 462.2 | 129.6 | 21.9% | 81.1 | 12.0 | (0.4) | 36.9 | 6.2% | |||||||||||||
Impacts of Fresh Start Accounting | - | - | - | (8.1) | (16.7) | (24.8) | 24.8 | 3.4 | - | - | 21.4 | |||||||||||||||
Restructuring and transition - personnel | - | - | - | (6.0) | 1.8 | (4.2) | 4.2 | (14.0) | (1.0) | - | 19.2 | |||||||||||||||
Transformation - other | - | - | - | 3.2 | (0.8) | 2.4 | (2.4) | (25.3) | (0.9) | (0.5) | 24.3 | |||||||||||||||
Refinancing related costs | - | - | - | - | - | - | - | (44.4) | - | - | 44.4 | |||||||||||||||
Held for sale non-core business | (6.6) | (6.0) | (12.6) | (7.9) | (2.6) | (10.5) | (2.1) | (6.1) | (5.8) | 0.9 | 8.9 | |||||||||||||||
Amortization of fair valued assets | - | - | - | - | - | - | - | (53.7) | - | - | 53.7 | |||||||||||||||
Legal deal matters | - | 2.8 | 2.8 | - | - | - | 2.8 | (4.6) | - | - | 7.4 | |||||||||||||||
Crisis in Ukraine costs | - | - | - | - | - | - | - | (0.1) | - | - | 0.1 | |||||||||||||||
Other | - | - | - | 0.3 | (0.1) | 0.2 | (0.2) | 0.3 | - | (0.2) | (0.3) | |||||||||||||||
Other impairment | - | - | - | - | - | - | - | - | - | (4.4) | 4.4 | |||||||||||||||
Non-GAAP Adjusted results | $ | 1,593.9 | $ | 1,120.0 | $ | 2,713.9 | $ | 1,130.0 | $ | 907.2 | $ | 2,037.2 | $ | 676.7 | 24.9 | % | $ | 395.3 | $ | 66.6 | $ | (0.1) | $ | 214.9 | 7.9 | % |
Nine months ended | ||||||||||||
September 30, 2024 | September 30, 2023 | |||||||||||
Successor | Combined* | |||||||||||
Services | Products | Total | Services | Products | Total | |||||||
Predecessor Gross Profit | $ | - | $ | - | $ | - | $ | 372.6 | $ | 147.4 | $ | 520.0 |
Successor Gross Profit | 397.0 | 291.4 | 688.4 | 79.4 | 50.2 | 129.6 | ||||||
Impacts of Fresh Start Accounting | - | - | - | 8.1 | 16.7 | 24.8 | ||||||
Restructuring and transition - personnel | 18.8 | 3.2 | 22.0 | 6.0 | (1.8) | 4.2 | ||||||
Transformation - other | 1.0 | - | 1.0 | (3.2) | 0.8 | (2.4) | ||||||
Held for sale non-core business | - | - | - | 1.3 | (3.4) | (2.1) | ||||||
Amortization of fair valued assets | 39.2 | 14.6 | 53.8 | - | - | - | ||||||
Legal deal matters | - | 1.5 | 1.5 | - | 2.8 | 2.8 | ||||||
Other | - | (1.1) | (1.1) | (0.3) | 0.1 | (0.2) | ||||||
Non-GAAP Adjusted Gross Profit | $ | 456.0 | $ | 309.6 | $ | 765.6 | $ | 463.9 | $ | 212.8 | $ | 676.7 |
Successor | Successor | Predecessor | ||||||||
Three months ended | Period from | Period from | Q3 2023 | |||||||
September 30, 2024 | 08/12/2023 through 09/30/2023 | 07/01/2023 through 08/11/2023 | Adjustments | Combined* | ||||||
Net income (loss) | $ | (21.7) | $ | (8.2) | $ | 2,150.7 | $ | (2,101.1) | $ | 41.4 |
Income tax expense | 29.9 | (13.2) | 94.1 | (93.3) | (12.4) | |||||
Interest income | (2.9) | (2.0) | (1.7) | - | (3.7) | |||||
Interest expense | 38.4 | 25.3 | 22.0 | (25.2) | 22.1 | |||||
Depreciation and amortization | 30.6 | 21.0 | 16.8 | (6.8) | 31.0 | |||||
EBITDA | 74.3 | 22.9 | 2,281.9 | (2,226.4) | 78.4 | |||||
Share-based compensation | 2.9 | - | 0.3 | - | 0.3 | |||||
Amortization of cloud-based software implementation costs | 1.0 | 0.5 | 0.3 | - | 0.8 | |||||
Foreign exchange loss (gain), net | 2.9 | 27.3 | (7.9) | (4.7) | 14.7 | |||||
Miscellaneous gain, net | (1.7) | 0.8 | (6.2) | 3.4 | (2.0) | |||||
Equity in earnings (loss) of unconsolidated subsidiaries, net | 1.5 | (1.1) | (0.2) | - | (1.3) | |||||
Restructuring and transformation expenses | 31.8 | 5.1 | 4.8 | - | 9.9 | |||||
Refinancing related costs | 2.1 | (0.3) | 0.1 | - | (0.2) | |||||
Non-routine (income) expense, net | 2.7 | 0.9 | 5.3 | - | 6.2 | |||||
Held for sale non-core business | - | 1.0 | 1.3 | - | 2.3 | |||||
Reorganization items, net | - | 8.0 | (2,250.3) | 2,242.3 | - | |||||
Adjusted EBITDA | $ | 117.5 | $ | 65.1 | $ | 29.4 | $ | 14.6 | $ | 109.1 |
Adjusted EBITDA as a % of revenue | 12.7 | % | 11.0 | % | 8.4 | % | 11.6 | % |
Successor | Successor | Predecessor | ||||||||
Nine months ended | Period from | Period from | Q3 YTD 2023 | |||||||
September 30, 2024 | 08/12/2023 through 09/30/2023 | 01/01/2023 through 08/11/2023 | Adjustments | Combined* | ||||||
Net income (loss) | $ | (20.9) | $ | (8.2) | $1,361.9 | $ | (1,464.9) | $ | (111.2) | |
Income tax expense | 58.8 | (13.2) | 90.4 | (93.3) | (16.1) | |||||
Interest income | (10.1) | (2.0) | (6.7) | - | (8.7) | |||||
Interest expense | 120.6 | 25.3 | 173.6 | (25.2) | 173.7 | |||||
Depreciation and amortization | 94.1 | 21.0 | 77.3 | (6.8) | 91.5 | |||||
EBITDA | 242.5 | 22.9 | 1,696.5 | (1,590.2) | 129.2 | |||||
Share-based compensation | 7.4 | - | 2.4 | - | 2.4 | |||||
Amortization of cloud-based software implementation costs | 3.8 | 0.5 | 2.0 | - | 2.5 | |||||
Foreign exchange loss (gain), net | (5.1) | 27.3 | 1.2 | (4.7) | 23.8 | |||||
Miscellaneous gain, net | (5.3) | 0.8 | (12.3) | 3.4 | (8.1) | |||||
Equity in earnings (loss) of unconsolidated subsidiaries, net | 2.9 | (1.1) | 0.5 | - | (0.6) | |||||
Restructuring and transformation expenses | 79.1 | 5.1 | 38.4 | - | 43.5 | |||||
Refinancing related costs | 14.0 | (0.3) | 44.7 | - | 44.4 | |||||
Non-routine (income) expense, net | 0.4 | 0.9 | 10.7 | - | 11.6 | |||||
Held for sale non-core business | - | 1.0 | 7.5 | - | 8.5 | |||||
Reorganization items, net | - | 8.0 | (1,614.1) | 1,606.1 | - | |||||
Adjusted EBITDA | $ | 339.7 | $ | 65.1 | $ | 177.5 | $ | 14.6 | $ | 257.2 |
Adjusted EBITDA as a % of revenue | 12.3 | % | 11.0 | % | 8.3 | % | 9.4 | % | ||
September 30, 2024 | December 31, 2023 | September 30, 2023 | ||||
Cash, cash equivalents, restricted cash and short-term investments (GAAP measure) | $ | 345.7 | $ | 605.7 | $ | 456.9 |
Debt instruments | (1,100.4) | (1,252.7) | (1,258.2) | |||
Net debt (Non-GAAP measure) | $ | (754.7) | $ | (647.0) | $ | (801.3) |
Three months ended | ||||||||||
September 30, 2024 | September 30, 2023 | |||||||||
($ in millions, except per share data) | Successor | per share | Combined* |
per share8
|
||||||
Net income (loss) | $ | (21.7) | $ | (0.58) | $ | 41.4 | $ | 0.52 | $ | 1.10 |
Net income (loss) attributable to noncontrolling interests | 0.7 | 0.02 | 0.5 | $ | 0.01 | 0.01 | ||||
Net income (loss) attributable to Diebold Nixdorf, Incorporated | $ | (22.4) | $ | (0.60) | $ | 40.9 | $ | 1.09 | ||
Restructuring and transformation expenses | 31.8 | 0.85 | 9.9 | 0.26 | ||||||
Refinancing related costs | 2.1 | 0.06 | (0.2) | (0.01) | ||||||
Held for sale non-core business | - | - | 2.3 | 0.06 | ||||||
Amortization of fair valued assets | 18.8 | 0.50 | 18.0 | 0.48 | ||||||
Divestitures and asset sales | - | - | - | - | ||||||
Legal deal matters | 1.2 | 0.03 | 4.4 | 0.12 | ||||||
Other | 1.5 | 0.04 | - | - | ||||||
Other Impairment | - | - | 1.7 | 0.05 | ||||||
Tax impact (inclusive of allocation of discrete tax items) | (13.2) | (0.35) | (162.8) | (4.33) | ||||||
Net income (loss) (Non-GAAP) | $ | 20.5 | $ | 0.55 | $ | (85.2) | $ | (2.27) | ||
Net income (loss) attributable to noncontrolling interests | 0.7 | 0.02 | 0.5 | 0.01 | ||||||
Total adjusted net income (loss) attributable to Diebold Nixdorf, Incorporated (Non-GAAP measure) | $ | 19.8 | $ | 0.53 | $ | (85.7) | $ | (2.28) |
Nine months ended | ||||||||
September 30, 2024 | September 30, 2023 | |||||||
($ in millions, except per share data) | Successor | per share | Combined* |
per share8
|
||||
Net income (loss) | $ | (20.9) | $ | (0.56) | $ | (111.2) | $ | (2.96) |
Net income (loss) attributable to noncontrolling interests | 1.2 | 0.03 | (0.1) | - | ||||
Net income (loss) attributable to Diebold Nixdorf, Incorporated | $ | (22.1) | $ | (0.59) | $ | (111.1) | $ | (2.96) |
Restructuring and transformation expenses | 79.1 | 2.10 | 43.5 | 1.16 | ||||
Refinancing related costs | 14.0 | 0.37 | 44.4 | 1.18 | ||||
Held for sale non-core business | - | - | 8.9 | 0.24 | ||||
Amortization of fair valued assets | 59.5 | 1.58 | 53.7 | 1.43 | ||||
Divestitures and asset sales | (2.6) | (0.07) | - | - | ||||
Crisis in Ukraine costs | - | - | 0.1 | - | ||||
Legal deal matters | 2.6 | 0.07 | 7.4 | 0.20 | ||||
Other | 0.4 | 0.01 | (0.3) | (0.01) | ||||
Other Impairment | - | - | 4.4 | 0.12 | ||||
Tax impact (inclusive of allocation of discrete tax items)9
|
(36.8) | (0.98) | (183.1) | (4.87) | ||||
Net income (loss) (Non-GAAP) | $ | 95.3 | $ | 2.52 | $ | (132.2) | $ | (3.51) |
Net income (loss) attributable to noncontrolling interests | 1.2 | 0.03 | (0.1) | - | ||||
Total adjusted net income (loss) attributable to Diebold Nixdorf, Incorporated (Non-GAAP measure) | $ | 94.1 | $ | 2.49 | $ | (132.1) | $ | (3.51) |